Gastric Cancer/ Stomach Cancer Market Size, Revenue, Growth, Trend & Forecast Analysis, 2020 - 2027, By Drug Type, By Disease Indication, By Route of Administration, By Country, & By Region

  • Report Id: HCDHR 2416
  • Published Date: August, 2020
  • No of Pages: 150
  • Format: Electronic (PDF)
  • Publisher: DataHorizzon Research
  • Category:

Gastric Cancer/ Stomach Cancer Market Report Overview

Gastric Cancer/ Stomach Cancer market garnered a revenue of USD 2.89 billion in the year 2019 globally and is anticipated to reach USD 9.54 billion by 2027, growing at a compound annual growth (CAGR) of 16.4% over the forecast period (2020-2027).The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.

Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.

Both the qualitative and quantitative aspects have been covered under the report. The Gastric Cancer/ Stomach Cancer market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.

What to expect from the report?

  • Gastric Cancer/ Stomach Cancer Total Available Market (TAM) Size
  • Gastric Cancer/ Stomach Cancer Serviceable Available Market (SAM) Size
  • Business Implications of COVID-19 on the Overall Market
  • Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2019)
  • Market Size & Forecast (2016-2027) At Country & Regional Level, By Segments
  • Overview & Analysis of Key Players Operating in the Market

Key Highlights:

Parameters

Description

COVID-19

Impact of COVID-19 on overall business scenario

Gastric Cancer/ Stomach Cancer Market Revenue 2020

Global market revenue in 2020 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic

Competitive Analysis

Company Market Share Analysis, 2019 (%)

Supply Chain Analysis

Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study

Data Route of Administration

Primary & Secondary Research, Internal Data Base & Company Annual Reports

Regions Included

North America, Europe, Asia Pacific, Latin America, & Middle East & Africa

Countries Included

U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa

Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Gastric Cancer/ Stomach Cancer Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. Gastric Cancer/ Stomach Cancer Market: Disease Indication Insights
4.1. Global Drug Type Historic Market Data & Future Forecasts, 2016-2027
4.2. Gastric Adenocarcinoma
4.2.1. Historic Market Data & Future Forecasts, 2016-2027
4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.3. Gastrointestinal Stromal Tumor (GIST)
4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4. Gastric Neuroendocrine Tumor (gNET)
4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 5. Gastric Cancer/ Stomach Cancer Market: Drug Type Insights
5.1. Global Disease Indication Historic Market Data & Future Forecasts, 2016-2027
5.2. Programmed Cell Death Protein 1 (PD-1) Inhibitors
5.2.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3. Human Epidermal Growth Factor Receptor (HER2) Antagonists
5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.2. Historic Market Data & Future Forecasts, By Region, 2016-2027
5.4. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.2. Historic Market Data & Future Forecasts, By Region, 2016-2027
5.5. Others
5.5.1. Historic Market Data & Future Forecasts, 2016-2027
5.5.2. Historic Market Data & Future Forecasts, By Region, 2016-2027
Chapter 6. Gastric Cancer/ Stomach Cancer Market: Route of Administration Insights
6.1. Global Route of Administration Historic Market Data & Future Forecasts, 2016-2027
6.2. Oral
6.2.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
6.3. Parenteral
6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 7. Gastric Cancer/ Stomach Cancer Market: Regional Insights
7.1. Global Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Region 2016-2027
7.2. North America
7.2.1. Historic Market Data & Future Forecasts, 2016-2027
7.2.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.2.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.2.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.2.5. U.S.
7.2.5.1. Historic Market Data & Future Forecasts, 2016-2027
7.2.5.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.2.5.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.2.5.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.2.6. Canada
7.2.6.1. Historic Market Data & Future Forecasts, 2016-2027
7.2.6.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.2.6.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.2.6.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.3. Europe
7.3.1. Historic Market Data & Future Forecasts, 2016-2027
7.3.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.3.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.3.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.3.5. U.K.
7.3.5.1. Historic Market Data & Future Forecasts, 2016-2027
7.3.5.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.3.5.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.3.5.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.3.6. Germany
7.3.6.1. Historic Market Data & Future Forecasts, 2016-2027
7.3.6.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.3.6.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.3.6.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.3.7. France
7.3.7.1. Historic Market Data & Future Forecasts, 2016-2027
7.3.7.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.3.7.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.3.7.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.4. Asia Pacific
7.4.1. Historic Market Data & Future Forecasts, 2016-2027
7.4.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.4.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.4.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.4.4.1. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.4.5. China
7.4.5.1. Historic Market Data & Future Forecasts, 2016-2027
7.4.5.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.4.5.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.4.5.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.4.6. India
7.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
7.4.6.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.4.6.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.4.6.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.4.7. Japan
7.4.7.1. Historic Market Data & Future Forecasts, 2016-2027
7.4.7.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.4.7.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.4.7.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.4.8. South Korea
7.4.8.1. Historic Market Data & Future Forecasts, 2016-2027
7.4.8.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.4.8.3.
7.4.8.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.4.8.5. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.5. Latin America
7.5.1. Historic Market Data & Future Forecasts, 2016-2027
7.5.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.5.3. Historic Market Data & Future Forecasts, By Drug Type t, 2016-2027
7.5.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.5.5. Brazil
7.5.5.1. Historic Market Data & Future Forecasts, 2016-2027
7.5.5.2. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.5.5.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.5.5.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.5.6. Mexico
7.5.6.1. Historic Market Data & Future Forecasts, 2016-2027
7.5.6.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.5.6.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.5.6.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.6. Middle East & Africa
7.6.1. Historic Market Data & Future Forecasts, 2016-2027
7.6.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.6.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.6.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.6.5. UAE
7.6.5.1. Historic Market Data & Future Forecasts, 2016-2027
7.6.5.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.6.5.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.6.5.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
7.6.6. South Africa
7.6.6.1. Historic Market Data & Future Forecasts, 2016-2027
7.6.6.2. Historic Market Data & Future Forecasts, By Disease Indication, 2016-2027
7.6.6.3. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.6.6.4. Historic Market Data & Future Forecasts, By Route of Administration, 2016-2027
Chapter 8. Company Profiles
8.1. Ipsen Pharma
8.1.1. Company Description
8.1.2. Financial Highlights
8.1.3. Product Portfolio
8.1.4. Strategic Initiatives
8.2. Jiangsu Hengrui Medicine Co., Ltd.
8.2.1. Company Description
8.2.2. Financial Highlights
8.2.3. Product Portfolio
8.2.4. Strategic Initiatives
8.3. Merck & Co., Inc.
8.3.1. Company Description
8.3.2. Financial Highlights
8.3.3. Product Portfolio
8.3.4. Strategic Initiatives
8.4. Eli Lilly
8.4.1. Company Description
8.4.2. Financial Highlights
8.4.3. Product Portfolio
8.4.4. Strategic Initiatives
8.5. F. Hoffmann-La Roche Ltd
8.5.1. Company Description
8.5.2. Financial Highlights
8.5.3. Product Portfolio
8.5.4. Strategic Initiatives
8.6. Bristol-Myers Squibb Company
8.6.1. Company Description
8.6.2. Financial Highlights
8.6.3. Product Portfolio
8.6.4. Strategic Initiatives
8.7. Celltrion Inc.
8.7.1. Company Description
8.7.2. Financial Highlights
8.7.3. Product Portfolio
8.7.4. Strategic Initiatives
8.8. Novartis AG
8.8.1. Company Description
8.8.2. Financial Highlights
8.8.3. Product Portfolio
8.8.4. Strategic Initiatives
8.9. TAIHO PHARMACEUTICAL CO., LTD.
8.9.1. Company Description
8.9.2. Financial Highlights
8.9.3. Product Portfolio
8.9.4. Strategic Initiatives
8.10. Bayer AG
8.10.1. Company Description
8.10.2. Financial Highlights
8.10.3. Product Portfolio
8.10.4. Strategic Initiatives

List of Tables
Table 1 Gastric Cancer/ Stomach Cancer Market Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 2 Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Region, 2016-2027 (USD Billion)
Table 3 Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 4 Gastric Adenocarcinoma Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 5 Gastrointestinal Stromal Tumor (GIST) Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 6 Gastric Neuroendocrine Tumor (gNET) Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 7 Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 8 Programmed Cell Death Protein 1 (PD-1) Inhibitors Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 9 Human Epidermal Growth Factor Receptor (HER2) Antagonists Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 10 Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 11 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 12 Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 13 Oral Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 14 Parenteral Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 15 Others Market Data & Future Forecasts, 201,m 6-2027 (USD Billion)

Table 16 North America Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 17 North America Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 18 North America Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 19 North America Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 20 U.S. Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 21 U.S. Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 22 U.S. Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 23 U.S. Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 24 Canada Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 25 Canada Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 26 Canada Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 27 Canada Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 28 Europe Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 29 Europe Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 30 Europe Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 31 Europe Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 32 U.K. Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 33 U.K. Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USBillion)
Table 34 U.K. Market Gastric Cancer/ Stomach Cancer Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 35 U.K. Market Gastric Cancer/ Stomach Cancer Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 36 Germany Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 37 Germany Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 38 Germany Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 39 Germany Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 40 France Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 41 France Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 42 France Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 43 France Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 44 Asia Pacific Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 45 Asia Pacific Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 46 Asia Pacific Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 47 Asia Pacific Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 48 China Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 49 China Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 50 China Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 51 China Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 52 India Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 53 India Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 54 India Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 55 India Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 56 Japan Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 57 Japan Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 58 Japan Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 59 Japan Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 60 South Korea Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 61 South Korea Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 62 South Korea Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 63 South Korea Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 64 Latin America Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 65 Latin America Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 66 Latin America Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 67 Latin America Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 68 Brazil Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 69 Brazil Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 70 Brazil Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 71 Brazil Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 72 Mexico Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 73 Mexico Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 74 Mexico Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 75 Mexico Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 76 Middle East & Africa Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 77 Middle East & Africa Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 78 Middle East & Africa Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 79 Middle East & Africa Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 80 UAE Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 81 UAE Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By DrugType, 2016-2027 (USD Billion)
Table 82 UAE Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 83 UAE Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)
Table 84 South Africa Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 85 South Africa Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Billion)
Table 86 South Africa Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Disease Indication, 2016-2027 (USD Billion)
Table 87 South Africa Gastric Cancer/ Stomach Cancer Market Data & Future Forecasts, By Route of Administration, 2016-2027 (USD Billion)

List of Figures
Fig.1 Data Analysis Model
Fig.2 Gastric Cancer/ Stomach Cancer Market, by 2016-2027 (USD Billion)
Fig.3 Gastric Cancer/ Stomach Cancer Market Segmentation
Fig.4 Supply chain analysis
Fig.5 Gastric Cancer/ Stomach Cancer Market Driver Anlaysis
Fig.6 Gastric Cancer/ Stomach Cancer Market Restraint Analysis
Fig.7 Gastric Cancer/ Stomach Cancer Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Gastric Cancer/ Stomach Cancer Market
Fig.10 Company Market Share Analysis, 2019

Gastric Cancer/ Stomach Cancer Market Segmentation:

Gastric Cancer/ Stomach Cancer Market, By Disease Indication (2016-2017)

  • Gastric Adenocarcinoma
  • Gastrointestinal Stromal Tumor (GIST)
  • Gastric Neuroendocrine Tumor (gNET)

Gastric Cancer/ Stomach Cancer Market, By Drug Type (2016-2027)

  • Programmed Cell Death Protein 1 (PD-1) Inhibitors
  • Human Epidermal Growth Factor Receptor (HER2) Antagonists
  • Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
  • Others

Gastric Cancer/ Stomach Cancer Market, By Route of Administration (2016-2027)

  • Oral
  • Parenteral

Gastric Cancer/ Stomach Cancer Market, By Region (2016-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • South Africa

Major Players Operating in the Gastric Cancer/ Stomach Cancer Market:

  • Ipsen Pharma
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Merck & Co., Inc.
  • Eli Lilly
  • Hoffmann-La Roche Ltd
  • Bristol-Myers Squibb Company
  • Celltrion Inc
  • Novartis AG
  • TAIHO PHARMACEUTICAL CO, LTD
  • Bayer AG

Choose License Type

Single user
$3,960
Multi User
$4,950
Enterprise User
$5,940
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.